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Ketamine is believed to reduce airway and pulmonary tissue resis-
tance. The aim of the present study was to determine the effects of
ketamine on the resistive, elastic and viscoelastic/inhomogeneous
mechanical properties of the respiratory system, lungs and chest wall,
and to relate the mechanical data to findings from histological lung
analysis in normal animals. Fifteen adult male Wistar rats were
assigned randomly to two groups: control (N = 7) and ketamine (N =
8). All animals were sedated (diazepam, 5 mg, ip) and anesthetized
with pentobarbital sodium (20 mg/kg, ip) or ketamine (30 mg/kg, ip).
The rats were paralyzed and ventilated mechanically. Ketamine in-
creased lung viscoelastic/inhomogeneous pressure (26%) compared
to the control group. Dynamic and static elastances were similar in
both groups, but the difference was greater in the ketamine than in the
control group. Lung morphometry demonstrated dilation of alveolar
ducts and increased areas of alveolar collapse in the ketamine group.
In conclusion, ketamine did not act at the airway level but acted at the
lung periphery increasing mechanical inhomogeneities possibly re-
sulting from dilation of distal airways and alveolar collapse.
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Ketamine is a general intravenous anes-
thetic that has been used since the sixties (1).
It is a non-narcotic and non-barbiturate drug
that induces sensorial dissociation in the pa-
tient. Especially due to its analgesic effects,
ketamine is frequently used both in humans
(2) and animals (3) either alone or in combi-
nation with other drugs.
The respiratory effects of ketamine (4)
are noticeable, mainly involving bronchodi-
lation (5), which was initially observed in
asthmatic patients. Supposedly, ketamine
relaxes the bronchiolar musculature and pre-
vents the bronchoconstriction induced by
histamine, which would be an obvious ad-
vantage for asthmatic patients. However, the
effects of ketamine on the respiratory system
in the absence of active smooth muscle tone
need to be clarified.
In this context, in the present study, the
mechanical properties of the respiratory sys-
tem, lung, and chest wall were subdivided
into their resistive, elastic, and viscoelastic
components during ketamine anesthesia in
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normal rats in order to pinpoint the sites of
action of this anesthetic agent. In addition,
histopathological studies were performed to
support the physiological findings. This mul-
tidisciplinary approach has not been used
previously.
Material and Methods
Fifteen male adult Wistar rats were ini-
tially sedated with diazepam (5 mg, ip) and
divided into two groups: control (CTRL,
280-300 g) - 7 rats anesthetized with pento-
barbital sodium (20 mg/kg, ip) and study
(KET, 270-310 g) - 8 rats anesthetized with
ketamine (30 mg/kg, ip). In both groups the
doses were enough to suppress the corneo-
palpebral reflex during the experiment, which
lasted no longer than 40 min.
After anesthesia, the animals were placed
in the supine position on a surgical table. A
snugly fitting cannula 1.5 mm in inner diam-
eter and 6.8 mm in length was introduced
into the trachea.
A pneumotachograph (6) (internal diam-
eter = 1.5 mm, length = 4.2 cm, distance
between side ports = 2.1 cm) was connected
to the tracheal cannula for airflow (V’) meas-
urements. The pressure gradient across the
pneumotachograph was determined using a
Validyne MP45-2 differential pressure trans-
ducer (Northridge, CA, USA). Volume (V)
was obtained by integration of the flow sig-
nal. Equipment resistive pressure was sub-
tracted from respiratory system and pulmo-
nary resistive pressures so that the results
reported reflect intrinsic mechanical proper-
ties. Because abrupt changes in diameter
were not present in our circuit, errors of
measurement of flow resistance were
avoided. The equipment dead space was 0.4
ml.
Tracheal pressure (Ptr) was measured
with a Hewlett-Packard 270 differential pres-
sure transducer (Waltham, MA, USA).
Changes in esophageal pressure (Pes), which
reflects chest wall pressure (Pw), were meas-
ured with a 30-cm long water-filled catheter
(PE-240) with side holes at the tip connected
to a PR23-2D-300 Statham differential pres-
sure transducer (Hato Rey, Puerto Rico).
The catheter was introduced into the stom-
ach and then slowly returned into the esopha-
gus and its proper positioning was assessed
using the “occlusion test” (7). The frequency
responses of the pressure measurement sys-
tem (Ptr and Pes) were flat up to 20 Hz,
without an appreciable phase shift between
signals. All signals were conditioned and
amplified with a Beckman type R Dynograph
(Schiller Park, IL, USA). Flow and pressure
signals were also passed through 8-pole
Bessel filters (902LPF, Frequency Devices,
Haverhill, MA, USA) with the corner fre-
quency set at 100 Hz, sampled at 200 Hz
with a 12-bit analogue-to-digital converter
(DT2801A, Data Translation, Marlboro, MA,
USA), and stored on a PC-compatible mi-
crocomputer. All data were collected using
LABDAT software (RHT-InfoData).
Muscle relaxation was achieved with gal-
lamine triethyliodide (2 mg/kg, ip), and arti-
ficial ventilation was provided by a Salziner
constant flow ventilator (Instituto do Coração,
USP, São Paulo, SP, Brazil). During the test
breaths, adjusting the ventilator settings gen-
erated a 5-s end-inspiratory pause, whereas
during the baseline ventilation no pause was
used. In order to avoid the effects of differ-
ent flows and volumes (8) and inspiratory
duration (9) on the variables measured, spe-
cial care was taken to keep volume (V = 2
ml) and flow (V’ = 10 ml/s) constant in all
animals. Breathing frequency remained con-
stant and equal to 100 breaths/min during the
experiment. The duration of inspiration (TI)
was set at 0.2 s and the duty cycle (TI/TT)
lasted 0.33 s.
Respiratory mechanics were measured
by end-inspiratory occlusion after constant
flow inflation (10). Briefly, after end-in-
spiratory occlusion, there is an initial fast
drop in tracheal pressure (DP1,rs) from the
pre-occlusion value down to an inflection
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point (Pi,rs), followed by a slow pressure
decay (DP2,rs) until a plateau is reached.
This plateau corresponds to the elastic recoil
pressure of the respiratory system (Pel,rs).
DP1,rs selectively reflects the combination
of airway, pulmonary and chest wall
Newtonian resistances in normal animals
(10-12) and in humans (13). DP2,rs reflects
stress relaxation, or viscoelastic properties
of the lung and chest wall tissues, together
with a small contribution of pendelluft in
normal situations (10-13). The same applies
to Pw, yielding the values of DP1,w, Pi,w,
DP2,w, and Pel,w, respectively. Transpul-
monary pressures (DP1,L, Pi,L, DP2,L, and
Pel,L) were calculated by subtracting the
chest wall pressure from the corresponding
values pertaining to the respiratory system.
The total pressure drop (DPtot) is equal to
the sum of DP1 and DP2, yielding the values
of DPtot,rs, DPtot,L, and DPtot,w. Respira-
tory system, lung, and chest wall static
elastances (Est,rs, Est,L, and Est,w, respec-
tively) were calculated by dividing Pel,rs,
Pel,L, and Pel,w, by total volume (VT), re-
spectively. Dynamic elastances of the respi-
ratory system, lung and chest wall (Edyn,rs,
Edyn,L, and Edyn,w, respectively) were ob-
tained by dividing Pi,rs, Pi,L, and Pi,w, by
VT, respectively. DE was calculated as the
difference Edyn-Est, yielding the values of
DE,rs, DE,L, and DE,w. The data concerning
respiratory system, lung, and chest wall
elastances were presented in terms of static
elastance and DE instead of dynamic
elastances, since they represent the elastic
and viscoelastic properties of the respiratory
system, respectively (9). Measurements of
the respiratory mechanics were performed
8-10 times in each animal in all instances.
Immediately before each data collection pe-
riod, the airways were aspirated to remove
possible collection of mucus, and the respi-
ratory system was inflated three times to
total lung capacity to maintain constant vol-
ume. The delay between the beginning and
the end of valve closure (10 ms) was calcu-
lated by back-extrapolation of the pressure
records to the actual time of occlusion and
the corrections in pressure, although very
minute, were performed (8). All data were
analyzed using the ANADAT data analysis
software (RHT-InfoData).
Immediately after the determination of
respiratory mechanics, with the animal still
alive, the trachea was clamped at end-expi-
ration, and the abdominal aorta and vena
cava were sectioned, yielding a massive hem-
orrhage that quickly killed the animals. Func-
tional residual capacity (FRC) was deter-
mined as follows: the lungs were rapidly
surgically removed (on average, it took 90 s
to remove them) and submerged into warm
(37oC) 0.9% NaCl solution (saline), the vol-
ume displaced was recorded, and the lungs
were weighed. FRC corresponds to the dif-
ference between the saline displaced (in ml)
and the lung weight (in g), assuming that the
tissue and saline have identical densities,
equal to 1.0 g/ml (14).
After the measurements of FRC the lungs
were quick-frozen by immersion in liquid
nitrogen for morphometric study (15). Tis-
sues were fixed in Carnoy’s solution (etha-
nol:chloroform:acetic acid, 70:20:10, v/v) at
-70oC for 24 h. Progressively increasing con-
centrations of ethanol at -20oC were then
substituted for Carnoy’s solution until 100%
ethanol was reached. Tissues were main-
tained at -20oC for 4 h, warmed to -4oC for
12 h and then allowed to reach and remain at
room temperature for 2 h. After fixation,
tissue blocks obtained from midsagittal slices
of the lungs at the level of the axial bronchus
were embedded in paraffin and cut into 4-
µm thick sections with a microtome. Coded
slices were stained with hematoxylin-eosin.
Microscopic examination was performed
by two investigators who were unaware of
the origin of the material during scoring.
Morphometric analysis was performed with
an integrating eyepiece with a coherent sys-
tem made of a 100-point grid consisting of
50 lines of known length, coupled to a con-
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ventional light microscope. The volume frac-
tion of collapsed and normal pulmonary ar-
eas, as well as the fraction of the lung occu-
pied by large-volume gas-exchanging air-
spaces (hyperinflation - structures with a
morphology distinct from that of alveoli and
wider than 120 µm) were determined by the
point-counting technique (15), carried out at
40X magnification across 10 random, non-
coincident microscopic fields.
The internal diameter of the alveolar ducts
was determined with the aid of a digital
analysis system and specific software (Im-
age-pro Plus 4.1, Media Cybernetics, Silver
Spring, MD, USA) at 100X magnification.
The images were generated by a microscope
(Axioplan, Zeiss, Oberkochen, Germany)
connected to a camera (Trinitron CCD, Sony,
Tokyo, Japan), fed into a computer through a
frame grabber (Oculus TCX, Coreco Inc.,
St. Laurent, PQ, Canada) for off-line pro-
cessing.
The luminal area of the central airways
was computed by counting the points falling
on the airway lumen and the points falling on
airway smooth muscle and on the epithe-
lium. The perimeters of the airways were
estimated by counting the intercepts of the
lines of the integrating eyepiece with epithe-
lial basement membrane. This procedure was
repeated four times for each airway. The
areas of smooth muscle and airway epithe-
lium were corrected in terms of airway pe-
rimeter by dividing their values by the num-
ber of intercepts of the line system with the
epithelial basement membrane of the corre-
sponding airway. Because the number of
intercepts (NI) of the lines with epithelial
basement membrane is proportional to the
airway perimeter and the number of points
(NP) falling on the airway lumen is propor-
tional to airway area, the magnitude of bron-
choconstriction [contraction index (CI)] was
computed by the equation: CI = NI/ NP.
All animals received humane care in com-
pliance with the “Principles of Laboratory
Animal Care” formulated by the National
Society for Medical Research and the “Guid-
ing Principles in the Care and Use of Ani-
mals” approved by the Council of the Ameri-
can Physiological Society.
In order to compare the results obtained
for the KET and CTRL groups the data were
first tested for normality by the Kolmogo-
rov-Smirnov test with Lilliefors’ correction,
and the homogeneity of variances was then
tested by the Levene median test. If both
conditions were satisfied, the Student t-test
was used. Spearman correlation was used to
correlate the functional parameters with the
morphometric parameters. The significance
level was always set at 5%.
Table 1. Respiratory data of rats anesthetized with
pentobarbital sodium or ketamine.
CTRL KET
Flow (ml/s) 10.16 ± 0.40 10.11 ± 0.43
Tidal volume (ml) 2.04 ± 0.05 1.99 ± 0.03
FRC (ml) 1.89 ± 0.39 2.14 ± 0.65
Respiratory system
DPtot,rs (cmH2O) 3.53 ± 0.35 4.28 ± 0.62*
DP1,rs (cmH2O) 1.91 ± 0.19 2.26 ± 0.55
DP2,rs (cmH2O) 1.61 ± 0.19 2.01 ± 0.32*
DE,rs (cmH2O/ml) 0.78 ± 0.10 1.01 ± 0.16*
Est,rs (cmH2O/ml) 3.15 ± 0.26 3.36 ± 0.46
Lung
DPtot,L (cmH2O) 2.77 ± 0.55 3.56 ± 0.72*
DP1,L (cmH2O) 1.47 ± 0.31 1.92 ± 0.60
DP2,L (cmH2O) 1.30 ± 0.25 1.64 ± 0.29*
DE,L (cmH2O/ml) 0.63 ± 0.12 0.82 ± 0.15*
Est,L (cmH2O/ml) 2.33 ± 0.36 2.55 ± 0.47
Chest wall
DPtot,w (cmH2O) 0.75 ± 0.24 0.70 ± 0.20
DP1,w (cmH2O) 0.44 ± 0.15 0.34 ± 0.15
DP2,w (cmH2O) 0.30 ± 0.11 0.36 ± 0.13
DE,w (cmH2O/ml) 0.14 ± 0.05 0.18 ± 0.06
Est,w (cmH2O/ml) 0.80 ± 0.19 0.80 ± 0.27
Values are reported as means ± SD for 7 animals
anesthetized with pentobarbital sodium (CTRL) and
8 rats anesthetized with ketamine (KET) (8-10 de-
terminations/rat). rs = respiratory system; L = lung;
w = chest wall; DPtot, DP1 and DP2 = total, resis-
tive and viscoelastic/inhomogeneous pressures,
respectively; Est = static elastance; DE = differ-
ence between dynamic and static elastances; FRC
= functional residual capacity.
*P<0.05 compared to the CTRL group (Student t-
test).
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Results
Flow and volume did not differ between
the CTRL and KET groups (Table 1). Respi-
ratory system and lung total pressure were
increased in the KET group as a result of
higher viscoelastic/inhomogeneous pulmo-
nary pressure (Table 1). The dynamic and
static elastances were similar in both groups.
However, the difference between the dy-
namic and static elastances of the respiratory
system and lungs were significantly higher
in the KET than in the CTRL group.
The mean (± SEM) percentages of nor-
mal, collapsed and hyperinflated areas, con-
traction index, and the internal diameter of
the alveolar ducts in the CTRL and KET
groups are shown in Table 2. It can be seen
that ketamine anesthesia yielded a higher
degree of alveolar collapse than those found
in the CTRL group. In addition, the internal
diameter of the alveolar ducts was higher in
the KET than in the CTRL group. The inter-
nal diameter of the central airways was simi-
lar in both groups.
Considering the CTRL and KET groups
together, viscoelastic/inhomogeneous pul-
monary pressure was well correlated with
the fraction of area of alveolar collapse (P =
0.04, r = 0.6) and the internal diameter of
alveolar ducts (P<0.0001, r = 0.85).
Discussion
The main finding of this study was that
ketamine anesthesia increased pulmonary vis-
coelastic/inhomogeneous pressure in rats
without pre-existing airway constriction. This
result was supported by the histological dem-
onstration of increased areas of alveolar col-
lapse and dilation of alveolar ducts, which
may yield a higher degree of inhomogene-
ities within the lung. In addition, ketamine
anesthesia did not alter lung resistive pres-
sure and there was no difference in the con-
traction index between CTRL and KET.
Ketamine is still considered the ideal
Table 2. Morphometric data of rats anesthetized with pentobarbital sodium or
ketamine.
Group Normal Alveolar Alveolar Contraction Internal diameter
collapse hyperinflation index of alveolar
ducts (µm)
CTRL 90.5 ± 0.9 7.4 ± 0.6 2.2 ± 0.4 0.11 ± 0.01 99 ± 4
KET 84.2 ± 1.2* 12.9 ± 1.2* 2.9 ± 0.5 0.12 ± 0.03 151 ± 10*
Values are reported as means ± SEM for 7 animals anesthetized with pentobarbital
sodium (CTRL) and 8 rats anesthetized with ketamine (KET). All values are percentage
of normal, collapsed and hyperinflated areas in 10 random, noncoincident fields per
rat.
*P<0.05 compared to the CTRL group (Student t-test).
anesthetic for asthmatic patients because it
decreases the risk of bronchospasm during
induction of anesthesia and preserves the
pulmonary vasoconstriction reflex to hy-
poxia. Thus, it has been recently compared
to the latest anesthetics, like propofol (3).
Ketamine causes bronchodilation in both
animals and humans, and exceptional results
have been obtained in asthmatic patients
(16).
Gallamine, an antagonist of muscarinic
M2-type receptors, was used to produce neu-
romuscular block and many studies have
shown that although the drug has anticholin-
ergic properties, airway resistance is un-
changed (17,18). Recently, it has been dem-
onstrated that gallamine and pentobarbital
did not significantly alter lung morphometry
in rats, with the mechanical properties prob-
ably being unchanged (19).
The great advantage of the end-inflation
occlusion method is the possibility of parti-
tioning the pressure used to insufflate the
respiratory system and its pulmonary and
chest wall components into their viscous or
resistive (DP1), viscoelastic/inhomogeneous
(DP2), and elastic (Pel) components. The
influence of V’ and V on the mechanical
parameters was demonstrated in several stud-
ies (8,9). In the present experiments V’ and
V were similar in both groups, thus permit-
ting a comparison of the results obtained for
the CTRL and KET groups.
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Since ketamine anesthesia did not alter
pulmonary resistive pressure dissipation
(DP1,L) (Table 1), we may conclude that
airway resistance did not change (19). In
addition, there was no difference in the inter-
nal diameters of central airways (contraction
index) between the CTRL and KET groups,
supporting the absence of changes in airway
resistance.
Ketamine is traditionally considered to
be a safe agent for asthmatic patients be-
cause it protects against bronchospastic at-
tacks and resolves symptoms of acute asthma
present at the time of induction (5). How-
ever, in the present study there was no func-
tional or histological evidence of bronchodi-
lation in normal rats anesthetized with keta-
mine. In this respect, Gateau et al. (20) re-
ported that ketamine did not influence the
basal tone of human bronchial preparations
but antagonized bronchial contraction pro-
duced by histamine and acetylcholine. The
diversity of methods used to determine lung
resistance, the variability in lung volume and
respiratory frequency, the differences in lung
preparations (in vivo versus in vitro), and the
smooth muscle tone of the airways may lead
to discrepant results.
As shown in Table 1, ketamine anesthe-
sia significantly increased pulmonary vis-
coelastic/inhomogeneous pressure. Lung his-
tology showed enlarged alveolar ducts, to-
gether with alveolar collapse (Table 2). The
precise effect of ketamine on lung periphery
is not known. Ketamine may dilate alveolar
ducts, thus changing the geometry of the
alveoli and yielding atelectasis. This hypo-
thesis is supported by the correlation be-
tween DP2,L and the internal diameter of
alveolar ducts and the fraction of alveolar
collapse. On the other hand, alveolar col-
lapse may pull open alveolar ducts. Under
these conditions the distribution of ventila-
tion could be altered, increasing mechanical
inhomogeneities.
Ketamine did not alter Est,L (Table 1),
thus indicating that the pulmonary elastic
component of the respiratory impedance did
not change under the present experimental
conditions. Functional residual capacity re-
mained unchanged in our study (CTRL: 1.89
± 0.39 ml vs KET: 2.14 ± 0.65 ml), in agree-
ment with some reports indicating that keta-
mine is unique in its ability to maintain FRC
upon the induction of anesthesia (21,22).
DE,rs and DE,L increased significantly
during ketamine anesthesia (Table 1), sug-
gesting that lung (and thus respiratory sys-
tem) viscoelasticity/inhomogeneity became
more prominent under the action of this
anesthetic agent. This finding was confirmed
by the increase in DP2,L (Table 1), as dis-
cussed above.
In summary, we confirmed that ketamine
does not act at the airway level but at the lung
periphery. Ketamine anesthesia in rats with-
out pre-existing airway constriction increased
the viscoelastic/inhomogeneous pressures
applied to the lung. This finding was sup-
ported by the histological demonstration of
increased areas of alveolar collapse and dila-
tion of alveolar ducts.
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